Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

FXR agonist 3

🥰Excellent
Catalog No. T74996

FXR agonist 3 is an anti-NASH compound with antifibrotic and anti-fibrotic activity, inhibiting the expression of COL1A1, TGF-β1, α-SMA, and TIMP1, with an IC50 value of 8.19 μmol/L for COL1A1. FXR agonist 3 ameliorates CDAHFD and BDL-induced liver injury in vivo by activating FXR.

FXR agonist 3

FXR agonist 3

🥰Excellent
Purity: 95.04%
Catalog No. T74996
FXR agonist 3 is an anti-NASH compound with antifibrotic and anti-fibrotic activity, inhibiting the expression of COL1A1, TGF-β1, α-SMA, and TIMP1, with an IC50 value of 8.19 μmol/L for COL1A1. FXR agonist 3 ameliorates CDAHFD and BDL-induced liver injury in vivo by activating FXR.
Pack SizePriceAvailabilityQuantity
1 mg$120 In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:95.04%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
FXR agonist 3 is an anti-NASH compound with antifibrotic and anti-fibrotic activity, inhibiting the expression of COL1A1, TGF-β1, α-SMA, and TIMP1, with an IC50 value of 8.19 μmol/L for COL1A1. FXR agonist 3 ameliorates CDAHFD and BDL-induced liver injury in vivo by activating FXR.
In vitro
In LX-2 cells, FXR agonist 3 (0, 2.5, 5, 7.5, and 10 μM; 24 hours; with or without 2 ng/mL TGF-β1 for another 24 hours) decreased COL1A1, TGF-β1, α-SMA, and TIMP1 protein expressions in a dose-dependent manner[1].
In vivo
In C57BL/6 N mice fed a CDAHFD diet for 16 weeks, FXR agonist 3 (200 mg/kg; oral gavage; daily for 4 weeks after CDAHFD-induced) decreased the expression of IL-1β and IL-6 in the liver[1].
Chemical Properties
Molecular Weight521.12
FormulaC28H28BrNO4
SmilesCOC1=CC2=C(C=C1OC)CC[N+]3=C2C=C4C(C(OCC5=CC=CC(C)=C5)=C(OC)C=C4)=C3.[Br-]
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 200 mg/mL (382.83 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9189 mL9.5947 mL19.1894 mL95.9472 mL
5 mM0.3838 mL1.9189 mL3.8379 mL19.1894 mL
10 mM0.1919 mL0.9595 mL1.9189 mL9.5947 mL
20 mM0.0959 mL0.4797 mL0.9595 mL4.7974 mL
50 mM0.0384 mL0.1919 mL0.3838 mL1.9189 mL
100 mM0.0192 mL0.0959 mL0.1919 mL0.9595 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy FXR agonist 3 | purchase FXR agonist 3 | FXR agonist 3 cost | order FXR agonist 3 | FXR agonist 3 chemical structure | FXR agonist 3 in vivo | FXR agonist 3 in vitro | FXR agonist 3 formula | FXR agonist 3 molecular weight